Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis

Biochemical Pharmacology

Volumn 84, Issue 3, 2012, Pages 303-311

  Finetti, Federica ^a   Basile, Anna ^b   Capasso, Domenica ^c   Di Gaetano, Sonia ^d   Di Stasi, Rossella ^d   Pascale, Maria ^b   Turco, Caterina Maria ^b   Ziche, Marina ^a   Morbidelli, Lucia ^a   D'Andrea, Luca Domenico ^d  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CNR   (Italy)

Author keywords

Angiogenesis; Endothelial cell; Nitric oxide; Peptide; Reparative medicine; VEGF

Indexed keywords

GLUTAMINYLLYSINE; PEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR RING; WOUND HEALING;

AMINO ACID SEQUENCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOMIMETIC MATERIALS; CATTLE; CELL LINE; CELLS, CULTURED; FEMALE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861989715     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.04.011     Document Type: Article

References (42)

1. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76. (Pubitemid 36749215)
2. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001;re21.
3. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010;141:1117-34.
4. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-71.
5. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 2003;28:488-94. (Pubitemid 38340413)
6. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19:2003-12. (Pubitemid 47354167)
7. D'Andrea LD, Del Gatto A, De Rosa L, Romanelli A, Pedone C. Peptides targeting angiogenesis related growth factor receptors. Curr Pharm Des 2009;15: 2414-29.
8. D'Andrea LD, Del Gatto A, Pedone C, Benedetti E. Peptide-based molecules in angiogenesis. Chem Biol Drug Des 2006;67:115-26. (Pubitemid 43881373)
9. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
10. Grothey A, Galanis E. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 2009;6:507-18.
11. D'Andrea LD, Iaccarino G, Fattorusso R, Sorriento D, Carannante C, Capasso D, et al. Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. Proc Natl Acad Sci USA 2005;102:14215-20. (Pubitemid 41429678)
12. Soro S, Orecchia A, Morbidelli L, Lacal PM, Morea V, Ballmer-Hofer K, et al. A proangiogenic peptide derived from vascular endothelial growth factor receptor- 1 acts through alpha5beta1 integrin. Blood 2008;111:3479-88.
13. Diana D, Basile A, De Rosa L, Di Stasi R, Auriemma S, Arra C, et al. Beta-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activity. J Biol Chem 2011;286:41680-91.
14. Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 1997;91:695-704. (Pubitemid 27513660)
15. Dudar GK, D'Andrea LD, Di Stasi R, Pedone C, Wallace JL. A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner. Am J Physiol Gastrointest Liver Physiol 2008;295:G374-81.
16. Santulli G, Ciccarelli M, Palumbo G, Campanile A, Galasso G, Ziaco B, et al. In vivo properties of the proangiogenic peptide QK. J Transl Med 2009;7:41 50.
17. Lee JS, Wagoner Johnson AJ, Murphy WL. A modular, hydroxyapatite-binding version of vascular endothelial growth factor. Adv Mater 2010;22:5494-8.
18. Leslie-Barbick JE, Saik JE, Gould DJ, Dickinson ME, West JL. The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide. Biomaterials 2011;32:5782-9.
19. Wang X, Horii A, Zhang S. Designer functionalized self-assembling peptide nanofiber scaffolds for growth, migration, and tubologenesis of human umbilical vein endothelial cells. Soft Matter 2008;4:2388-95.
20. Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW, et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci USA 2011;108:13438-43.
21. Diana D, Ziaco B, Colombo G, Scarabelli G, Romanelli A, Pedone C, et al. Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide. Chemistry 2008;14:4164-6.
22. Diana D, Ziaco B, Scarabelli G, Pedone C, Colombo G, D'Andrea LD, et al. Structural analysis of a helical peptide unfolding pathway. Chemistry 2010;16:5400-7.
23. Schelling ME, Meininger CJ, Hawker Jr JR, Granger HJ. Venular endothelial cells from bovine heart. Am J Physiol 1988;254:H1211-17.
24. Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, Bungay PM, et al. Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am J Pathol 2003;162:1431-9. (Pubitemid 36512825)
25. Donnini S, Solito R, Giachetti A, Granger HJ, Ziche M, Morbidelli L. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium. J Pharmacol Exp Ther 2006;319: 515-22.
26. Finetti F, Solito R, Morbidelli L, Giachetti A, Ziche M, Donnini S. Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. J Biol Chem 2008;283:2139-46.
27. Morbidelli L, Pyriochou A, Filippi S, Vasileiadis I, Roussos C, Zhou Z, et al. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability. Am J Physiol Regul Integr Comp Physiol 2010;298:R824-32.
28. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-5.
29. Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N, Zioncheck TF. Homologous upregulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 1998;273:29979-85. (Pubitemid 28510016)
30. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011;146:873-87.
31. Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 2001;276:3222-30.
32. Takahashi T, Yamaguchi S, Chida K, Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001;20:2768-78. (Pubitemid 32938560)
33. Dayanir V, Meyer RD, Lashkari K, Rahimi N. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem 2001;276:17686-92.
34. Fujio Y, Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999;274:16349-54.
35. Thakker GD, Hajjar DP, Muller WA, Rosengart TK. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 1999;274:10002-07.
36. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
37. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factorinduced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001;98:2604-9. (Pubitemid 32209529)
38. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625-34. (Pubitemid 27259809)
39. Lee PC, Salyapongse AN, Bragdon GA, Shears II LL, Watkins SC, Edington HDJ, et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999;277:H1600-08. (Pubitemid 29522694)
40. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis. Nat Med 2000;6:1102-3.
41. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005;437:497-504. (Pubitemid 41613541)
42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. (Pubitemid 34164012)